NEWS
Washington Post: Upbeat news on a possible coronavirus treatment powers U.S. stocks, lifting Dow more than 500 points
AmCham News tags
- Accounting / Financial
- AmCham Norway
- Company Profiles
- Education / Research
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Hotel/ Restaurants/ Conferences
- Insurance
- International Leadership Interview Series
- Membership Guide
- Publications
- Rising Leaders
- Technology
- Trade
- Travel
Business News tags
- Accounting / Financial
- Airline / Travel
- Automobile / Transport
- Chemicals / Metals
- Communications/PR/Media
- Culture / Lifestyle
- Defense / Security
- Education / Research
- Energy
- Entertainment & Lifestyle
- Financial / Investment
- Food & Beverage
- Government
- Health
- Human Resources
- Insurance
- IP & Innovation
- Legal
- Management Consulting
- Manufacturing
- Pharmaceutical
- Politics
- Property / Real Estate
- Seafood
- Shipping & Offshore
- Statistics
- Tax
- Technology
- Trade
< Back to all news
Washington Post: Upbeat news on a possible coronavirus treatment powers U.S. stocks, lifting Dow more than 500 points
Business
Date posted: 30.04.2020
Category: Business News
Wednesday’s rally picked up steam after Gilead Sciences reported “positive data” coming from the National Institute of Allergy and Infectious Diseases’ clinical trial of its investigational remdesivir treatment for covid-19. The company said “the trial has met its primary endpoint.”
Read entire article HERE.
Source: Washington Post